http://rdf.ncbi.nlm.nih.gov/pubchem/reference/34592755

Outgoing Links

Predicate Object
contentType Journal Article|Randomized Controlled Trial|Research Support, Non-U.S. Gov't
endingPage 665
issn 1387-2877
1875-8908
issueIdentifier 2
pageRange 653-665
publicationName Journal of Alzheimer's disease : JAD
startingPage 653
bibliographicCitation Agger MP, Danielsen ER, Carstensen MS, Nguyen NM, Horning M, Henney MA, Jensen CBR, Baandrup AO, Kjær TW, Madsen KH, Miskowiak K, Petersen PM, Høgh P. Safety, Feasibility, and Potential Clinical Efficacy of 40 Hz Invisible Spectral Flicker versus Placebo in Patients with Mild-to-Moderate Alzheimer's Disease: A Randomized, Placebo-Controlled, Double-Blinded, Pilot Study. J Alzheimers Dis. 2023;92(2):653–65. doi: 10.3233/jad-221238. PMID: 36776073.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_13282c8e68cf5a8db0a8885d6d61f435
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_832d9a32a835d26603c2d38647ba5972
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_42018c6b4316772f83b27dafea4fff12
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_292b89fbb5edf3759bb0d16f74c645fa
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_aef1fbdfe951c9e699a2ba9c50b5c990
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4c2245a1f4f38d13b9b9c08d9b7c991d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3f22ed810556b1d8519b6ae7c3231875
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9de6c6b77d465639aafe608bcdb718f7
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bf415c2f651b5ef144ac16d9793ebd88
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ce96f020f86b7ba49e2ef5ff4a98389d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4794136534b6ba606b3027282e502fa7
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0c7082070d2a456d836fa362a2e1e01c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8e71821d9da117fb93dcf0127eb35e41
date 2023-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/36776073
https://doi.org/10.3233/jad-221238
isPartOf https://portal.issn.org/resource/ISSN/1387-2877
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/21942
https://portal.issn.org/resource/ISSN/1875-8908
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Safety, Feasibility, and Potential Clinical Efficacy of 40 Hz Invisible Spectral Flicker versus Placebo in Patients with Mild-to-Moderate Alzheimer’s Disease: A Randomized, Placebo-Controlled, Double-Blinded, Pilot Study
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D000544Q000145
http://id.nlm.nih.gov/mesh/D000544Q000628
http://id.nlm.nih.gov/mesh/D010789Q000009
http://id.nlm.nih.gov/mesh/D010789Q000379
http://id.nlm.nih.gov/mesh/D000544Q000175
hasSubjectTerm http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D000368
http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D004311
http://id.nlm.nih.gov/mesh/D005240
http://id.nlm.nih.gov/mesh/D016896
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D010865
http://id.nlm.nih.gov/mesh/D008875

Total number of triples: 46.